1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Yes, Sandi mentioned that too. I think the topic of combination antibodies and the resulting responses is a complex/advanced issue and would be better served by an entirely separate and new page. A page which would be linked to.Rob16 wrote: ...Perhaps you might add some combination rows to your table, especially Type 3 plus Type 4, since that combo is so common...
This is an interesting question. A question which needs due diligence and a good answer. Can you convince me the response is the worse of the two instead of the sum of the two?Rob16 wrote: ...You said that would be a "good" IVIG response (between the two)? I would have guessed the worse of the two, or "Weak". What is the Typical Promacta Response? Intermediate, or the highest dose? ...
Type assignments were made per the response definitions and the definitions were created from observation of the data. Obviously the data is only what someone reports, is not unbiased, and is often incomplete. This is the major problem innate to 'retrospective' studies.Rob16 wrote: ...Is there any way to aggregate your raw data and post it so that someone else might be able to see your work? For example, on what basis were people assigned to a specific type? How many people fell into each type, and how well did your data fit your model? ...
I've tried to explain the basis of the assignments already, earlier in this thread. If the basis looks weak, it is because it is weak.Rob16 wrote: ...Have you summarized somewhere the theoretical or statistical basis for assigning each combination of steroid/IVIG response to a specific antibody type?
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.
Platelet Disorder Support Association
8751 Brecksville Road, Suite 150, Cleveland, Ohio 44141
Phone: 1-87-PLATELET | 877-528-3538 (toll free) | or 440-746-9003
E-mail: pdsa@pdsa.org
© Copyright 1997 - 2024, Platelet Disorder Support Association. All rights reserved.
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.